(Q46068158)

19 December 2017

title

Pharmaceuticals, political money, and public policy: a theoretical and empirical agenda (English)

1 reference

19 December 2017

author name string

Paul D Jorgensen

series ordinal

1

1 reference

19 December 2017

publication date

1 January 2013

1 reference

19 December 2017

Journal of Law, Medicine, and Ethics

published in

1 reference

19 December 2017

volume

41

1 reference

19 December 2017

issue

3

1 reference

19 December 2017

page(s)

561-570

1 reference

19 December 2017

Corruption of pharmaceutical markets: addressing the misalignment of financial incentives and public health

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12065

Conflicts of interest, institutional corruption, and pharma: an agenda for reform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12065

Five un-easy pieces of pharmaceutical policy reform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12065

Lobbying as Legislative Subsidy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12065

Challenging Pharmaceutical Industry Political Power in Maine and Vermont

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12065

The Disproportionate Impact of Voter-ID Requirements on the Electorate—New Evidence from Indiana

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJLME.12065

21 January 2018

Identifiers

DOI

10.1111/JLME.12065

1 reference

19 December 2017

1 reference

19 December 2017